FOAMIX SIGNS AGREEMENT WITH TARO ON LICE TREATMENT

Israeli start-up Foamix Ltd. yesterday signed an agreement with Taro Pharmaceutical Industries Ltd. to develop a treatment for lice. Founded three years ago, Foamix develops proprietary foams for drug delivery. The non-alcoholic foam is easily absorbed by the skin, making it more effective for drug delivery than creams and gels now on the market. Globes (http://www.globes.co.il/serveen/globes/DocView.asp?did=1000142813&fid=1725)